Physician profile
David M Skeehan
NPI 1629289186
$90,910.17
in general payments reported to CMS, 2019-2025
26 companies · $8,853 in 2025
The $8,853 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,934 · 2020: $14K · 2021: $4,076 · 2022: $24K · 2023: $24K · 2024: $9,854 · 2025: $8,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $4,949 · Food and Beverage: $3,275 · Gift: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,450.00 |
| Travel and Lodging | $4,949.46 |
| Food and Beverage | $3,274.53 |
| Gift | $179.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $49,161.82 | 2021-2025 | Progrip, Ligasure, Bio-Flek |
| Intuitive Surgical, INC. | $36,032.74 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $2,420.00 | 2022 | |
| Davol INC. | $1,749.57 | 2019-2023 | Phasix Mesh |
| Conmed Corporation | $238.17 | 2022 | |
| Ethicon US, LLC | $220.83 | 2021-2025 | Linx Reflux Management System, Monocryl, Dermabond Prineo |
| Tela Bio, INC. | $167.97 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endogastric Solutions, INC | $134.04 | 2023 | Esophyx |
| Becton, Dickinson and Company | $129.37 | 2023-2025 | Phasix Mesh, Arista Ah Flexitip |
| Integra Lifesciences Corporation | $128.54 | 2020-2025 | Integra, Surgimend, Omnigraft |
| Organogenesis INC. | $88.28 | 2021-2023 | Puraply |
| Innocoll Pharmaceuticals Limited | $64.37 | 2021-2022 | |
| Lsi Solutions INC | $44.02 | 2022 | |
| Allergan, INC. | $42.53 | 2021-2022 | |
| Hologic Sales and Service, LLC | $35.53 | 2024-2025 | Magtrace, Magseed, Trident Specimen Radiography System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $34.76 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Myriad Genetic Laboratories, INC. | $27.66 | 2024 | Myrisk |
| Pacira Pharmaceuticals Incorporated | $26.37 | 2024 | Exparel |
| Polynovo North America LLC | $23.69 | 2024 | Novosorb Btm |
| Takeda Pharmaceuticals U.S.A., INC. | $23.39 | 2023 | Gattex |
| Smith+Nephew, INC. | $23.37 | 2023 | Renasys Go V2 Home |
| Elucent Medical | $21.95 | 2025 | |
| Braintree Laboratories, INC. | $20.94 | 2025 | Suflave |
| Acell, INC. | $18.07 | 2020 | |
| Medela LLC | $17.89 | 2020 | |
| Zyla Life Sciences, INC. | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Skeehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.